SWA
GNOM icon

Sightline Wealth Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Sightline Wealth Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540K Sell
9,502
-182
-2% -$8.68K 0.2% 55
2026
Q1 		$424K Buy
9,684
+55
+0.6% +$2.54K 0.18% 59
2025
Q4 		$438K Sell
9,629
-1,203
-11% -$53.3K 0.19% 62
2025
Q3 		$421K Sell
10,832
-1,575
-13% -$57K 0.19% 62
2025
Q2 		$418K Sell
12,407
-387
-3% -$12.3K 0.2% 60
2025
Q1 		$407K Sell
12,794
-2,690
-17% -$102K 0.21% 55
2024
Q4 		$601K Sell
15,484
-827
-5% -$34.7K 0.32% 44
2024
Q3 		$734K Sell
16,311
-150
-0.9% -$6.71K 0.4% 41
2024
Q2 		$687K Buy
16,461
+950
+6% +$39.7K 0.43% 39
2024
Q1 		$706K Sell
15,511
-450
-3% -$20.5K 0.47% 35
2023
Q4 		$738K Sell
15,961
-2,113
-12% -$86.1K 0.56% 35
2023
Q3 		$735K Buy
18,074
+16
+0.1% +$728 0.69% 34
2023
Q2 		$890K Hold
18,058
– – 0.88% 26
2023
Q1 		$890K Sell
18,058
-275
-2% -$14.2K 0.91% 24
2022
Q4 		$928K Buy
18,333
+4,728
+35% +$244K 1% 24
2022
Q3 		$685K Buy
13,605
+3,364
+33% +$190K 0.8% 20
2022
Q2 		$501K Buy
10,241
+5,247
+105% +$266K 0.49% 30
2022
Q1 		$300K Buy
4,994
+1,273
+34% +$80.3K 0.25% 44
2021
Q4 		$291K Buy
+3,721
New +$313K 0.26% 39

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return

Sightline Wealth Advisors's GNOM Position: Q2 2026 in Review

Sightline Wealth Advisors reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 1.9% in Q2 2026, selling an estimated $8.68K and leaving 9,502 shares worth $540K. The position accounts for 0.2% of the portfolio, ranked #55.

Sightline Wealth Advisors first reported a position in GNOM in Q4 2021 and has held it in 19 quarters since. The position peaked at $928K in Q4 2022. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Sightline Wealth Advisors held 9,502 shares of Global X Genomics & Biotechnology ETF worth $540K as of Q2 2026.
  • Sightline Wealth Advisors sold 182 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $8.68K.
  • Global X Genomics & Biotechnology ETF made up 0.2% of Sightline Wealth Advisors's portfolio in Q2 2026, its #55 holding.
  • Sightline Wealth Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • Sightline Wealth Advisors's Global X Genomics & Biotechnology ETF position peaked at $928K in Q4 2022.
  • 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Sightline Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.